Results 181 to 190 of about 21,216 (279)

Clinical experience of raltegravir-containing regimens in HIV-infected patients during rifampicin-containing treatment of tuberculosis [PDF]

, 2011
Bello, Laura, Castro-Iglesias, Ángeles, López, Soledad, Mena, Álvaro, Pedreira, José D., Vázquez-Rodríguez, Pilar   +5 more
core   +2 more sources

Excellent short-term CD4 recovery with a PI- and NRTI-sparing regimen in triple-class failure HIV-infected patients: raltegravir, maraviroc, etravirine [PDF]

, 2008
Silvia Nozza, Francesca Visco, A Soria, Laura Galli, Stefania Salpietro, Nicola Gianotti, Elisabetta Carini, Alba Bigoloni, Giuliana Fusetti, Giuseppe Tambussi, Adriano Lazzarin, Antonella Castagna   +11 more
openalex   +1 more source

Herbal formulations, Product Nkabinde and <i>Gnidia sericocephala</i>, exhibit potent <i>in vitro</i> activity against HIV-1 infection. [PDF]

Front Pharmacol
Mngomezulu K, Madlala P, Nkabinde SA, Nkabinde M, Ngcobo M, Gqaleni N.   +5 more
europepmc   +1 more source

Raltegravir and Abacavir/Lamivudine in Japanese Treatment-Na&iuml;ve and Treatment-Experienced Patients with HIV Infection: a 48-Week Retrospective Pilot Analysis

, 2015
Akihito Suzuki, Yuki Uehara, Mizue Saita, Akihiro Inui, Hiroshi Isonuma, Toshio Naito   +5 more
openalex   +2 more sources

Formulation and evaluation of raltegravir microspheres

Mekala Shiva Prasad, Banothu Srikanth, P. Abhilash, P. Betti Nayomi, P. Chandrika, P. Pranavi, P. Sharath   +6 more
openalex   +2 more sources

Analysis of raltegravir analogs to enhance inhibitory efficiency against HIV integrase. [PDF]

Sci Rep
Sabaghian H, Yoosefian M.
europepmc   +1 more source

The transmembrane nucleoporin Nup210 weakens HIV-1 infection via modulating late events of viral nuclear import. [PDF]

AIDS
Wang L, Li SM, Li X, Wu HS, Ma C, Wang DB, Zhang XE.   +6 more
europepmc   +1 more source

Elimination of HIV Reservoirs Harboring Intact Proviruses. [PDF]

J Infect Dis
Li M, Truong K, Sharma S, Sun B, Chen M, Kimata JT, Wang J.   +6 more
europepmc   +1 more source

Cellular determinants of raltegravir exposure

, 2019
Darren Moss
openalex   +1 more source

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Chen M, Gandhi-Patel B, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Scerpella EG, Chaudhari P, Jarrett J.   +10 more
europepmc   +1 more source